PlainPharmaWatch

CMS Open Payments · Program Year 2024

Fortis Surgical, LLC

Fortis Surgical, LLC reported $45,563.47 across General Payments, Research, and Ownership to 464 physicians and teaching hospitals across 464 transactions.

$45.6K
All-tracks total
464
Transactions
464
Recipients
+$12.5K
General Payments vs PY2023

Fortis Surgical, LLC reported $45,563.47 across all CMS Open Payments tracks (General + Research + Ownership) to 464 physicians and teaching hospitals in Program Year 2024 - ranking #1375 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $45,563.47, averaging $98.20 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer fortis-surgical-llc Fortis Surgical, LLC

$45.6K · #1375/1,925 · 0.0% industry · PY2024

  • TOT $45.6K
  • RANK #1375
  • SHARE 0.0%
  • TXN 464
  • RCP 464
  • CAT 2
  • GEN $45.6K
  • ΔGEN +$12.5K
  • TOP1 4.5%
  • PY 2024

Nearest volume peer: Microline Surgical Inc ($45.6K)

Hartmann USA, Inc.$45.9KMicroline Surgical Inc$45.6KFortis Surgical, LLC (this)$45.6KMercator MedSystems, Inc.$45.4KHollister Incorporated$45.3K
All-tracks payment totals near Fortis Surgical, LLC (CMS Open Payments PY2024)

Fortis Surgical, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Fortis Surgical, LLC's CMS-reported General Payments increased by $12.5K (+37.8%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: FORTIS SURGICAL, LLCPY2023: FORTIS SURGICAL, LLCPY2024: Fortis Surgical, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$33.1KPY2024$45.6K
PY2023
$33,068.16
PY2024
$45,563.47

What the Data Shows for Fortis Surgical, LLC

In Program Year 2024, Fortis Surgical, LLC reported $45,563.47 in payments to 464 physicians and teaching hospitals across 464 individual transactions, an average of $98.20 per transaction and $98.20 per recipient. That total places Fortis Surgical, LLC at rank #1375 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Travel and Lodging" leads the 2-category general-payment breakdown below at $29.4K (64.5% of General Payments, 83 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Fortis Surgical, LLC made 2 types of general payments. "Travel and Lodging" is the largest category at $29.4K, 64.5% of General Payments.

How Fortis Surgical, LLC divides its payments

Top payment categories by total reported dollar volume

1. Travel and Lodging$29.4K2. Food and Beverage$16.2K
Payment Type Amount Transactions
Travel and Lodging $29.4K 83
Food and Beverage $16.2K 381

Recipient Concentration in General Payments

The five largest recipient relationships account for $8,056.84 (17.7%) of $45,563.47 in this company's General Payments records across 231 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Fortis Surgical, LLC

The five named recipients with the highest reported General Payments from this company

Victoria Matt$2.0KBrian Huff$2.0KJessica Bruno$1.4KBryanna Vesely$1.4KJennifer Vanderbeck$1.2K
  1. 1

    Victoria Matt

    $2,038.29 across 5 reported transactions

  2. 2

    Brian Huff

    $2,022.80 across 10 reported transactions

  3. 3

    Jessica Bruno

    $1,409.27 across 9 reported transactions

  4. 4

    Bryanna Vesely

    $1,371.26 across 10 reported transactions

  5. 5

    Jennifer Vanderbeck

    $1,215.22 across 9 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Fortis Surgical, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fortis Surgical, LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Fortis Surgical, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Fortis Surgical, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.